BioXcel Therapeutics Inc (BTAI)
2.18
-0.06
(-2.90%)
USD |
NASDAQ |
Mar 26, 16:00
2.19
+0.01
(+0.46%)
After-Hours: 20:00
BioXcel Therapeutics Shareholders Equity (Quarterly): -85.63M for Sept. 30, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Omeros Corp | -154.17M |
| Chimerix Inc | 121.68M |
| scPharmaceuticals Inc | 13.32M |
| IGM Biosciences Inc | 48.17M |
| ZyVersa Therapeutics Inc | 7.027M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.89M |
| Total Liabilities (Quarterly) | 134.52M |
| Debt to Equity Ratio | -1.220 |
| Current Ratio | 1.87 |
| Net Debt Paydown Yield | -5.86% |